Perspectives on Nitric Oxide in Disease Mechanisms: Request for Book Review Writing on Amazon.com
Reporter: Aviva Lev-Ari, PhD, RN
http://www.amazon.com/dp/B00DINFFYC
PRLog site Press Release
Perspectives on Nitric Oxide in Disease Mechanisms
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B00DINFFYC
PRLog site Press Release
Table of Contents
Chapter 1:
Nitric Oxide Basic Research
1.1 Discovery of Nitric Oxide
1.1.1 Discovery of Nitric Oxide and its Role in Vascular Biology
Aviral Vatsa, PhD, MBBS
1.1.2 Nitric Oxide: The Nobel Prize in Physiology or Medicine
Aviva Lev-Ari, PhD, RN
1.2 Nitric Oxide Synthase(s)
1.2.1 Nitric Oxide: A Short Historic Perspective
Aviral Vatsa, PhD, MBBS
1.2.2 Nitric Oxide: Role in Cardiovascular Health and Disease
Aviral Vatsa, PhD, MBBS
1.3 Endothelial Blood Cell Interactions: Platelet, Leukocyte and Monocyte
1.3.1 Nitric Oxide: Chemistry and Function
Aviral Vatsa, PhD, MBBS
1.4 Signaling Pathways
1.4.1 Nitric Oxide Signaling Pathways
Aviral Vatsa, PhD, MBBS
1.4.2 Nitric Oxide has a Ubiquitous Role in the Regulation of Glycolysis – with a Concomitant Influence on Mitochondrial Function
Larry H. Bernstein, MD, FCAP
1.5 Oxidative Stress
1.5.1 Mitochondrial Damage and Repair under Oxidative Stress
Larry H. Bernstein, MD, FCAP
1.6 Oxygen and Nitrogen Reactive Species
1.6.1 Interaction of Nitric Oxide and Prostacyclin in Vascular Endothelium
Larry H Bernstein, MD, FCAP
1.6.2 Prostacyclin and Nitric Oxide: Adventures in vascular biology – a tale of two mediators
Aviva Lev-Ari, PhD, RN
Chapter 2:
Nitric Oxide and Circulatory Diseases
2.1 Endothelial Dysruption and Denudation
2.1.1 Blood-vessels-generating Stem Cells Discovered
Ritu Saxena, PhD
2.1.2 Differential Distribution of Nitric Oxide – A 3-D Mathematical Model
Anamika Sarkar, PhD
2.1.3 Nitric Oxide Nutritional Remedies for Hypertension and Atherosclerosis. It’s 12AM: Do you know where your electrons are?
Meg Baker, PhD
2.2 Endothelin and ET Receptors
2.2.1 Statins’ Nonlipid Effects on Vascular Endothelium through eNOS Activation
Larry H Bernstein, MD, FCAP
2.2.2 Endothelial Function and Cardiovascular Disease
Larry H Bernstein, MD, FCAP
2.2.3 Endothelin Receptors in Cardiovascular Diseases: The Role of eNOS Stimulation: Observations on Intellectual Property Development for an Unrecognized Future Fast Acting Therapy for Patients at High Risk for Macrovascular Events
Aviva Lev-Ari, PhD, RN
Chapter 3:
Therapeutic Cardiovascular Targets
3.1 Nitric oxide and therapeutic Targets
3.1.1 Cardiovascular Disease (CVD) and the Role of Agent Alternatives in Endothelial Nitric Oxide Synthase (eNOS) Activation and Nitric Oxide Production
Aviva Lev-Ari, PhD, RN
3.1.2 Telling NO to Cardiac Risk
Stephen W Williams, PhD
3.1.3 Nitric Oxide and its Impact on Cardiothoracic Surgery
Tilda Barliya PhD
3.2 Therapeutic opportunities for Endothelial Progenitor Cells
3.2.1 Inhibition of ET-1, ETA and ETA-ETB, Induction of Nitric Oxide production, stimulation of eNOS and Treatment Regime with PPAR-gamma agonists (TZD): eEPCs Endogenous Augmentation for Cardiovascular Risk Reduction – A Bibliography
Aviva Lev-Ari, PhD, RN
3.2.2 Bystolic’s generic Nebivolol – Positive Effect on circulating Endothelial Progenitor Cells Endogenous Augmentation
Aviva Lev-Ari, PhD, RN
3.2.3 Positioning a Therapeutic Concept for Endogenous Augmentation of cEPCs — Therapeutic Indications for Macrovascular Disease: Coronary, Cerebrovascular and Peripheral
Aviva Lev-Ari, PhD, RN
3.2.4 Endothelial Dysfunction, Diminished Availability of cEPCs, Increasing CVD Risk for Macrovascular Disease – Therapeutic Potential of cEPCs
Aviva Lev-Ari, PhD, RN
3.3 Hypertension, Congestive Heart Failure and Endothelin Biomarker
3.3.1 Clinical Trials Results for Endothelin System: Pathophysiological Role in Chronic Heart Failure, Acute Coronary Syndromes and MI – Markers of Disease Severity or Genetic Determination?
Aviva Lev-Ari, PhD, RN
3.4 Hypotension and Shock: Cardiovascular Collapse
3.4.1 Nitric Oxide and Sepsis, Hemodynamic Collapse and the Search for Therapeutic Options
Larry H Bernstein, MD, FCAP
3.4.2 Sepsis, Multi-organ Dysfunction Syndrome, and Septic Shock: A Conundrum of Signaling Pathways Cascading Out of Control
Larry H Bernstein, MD, FCAP
3.5 Hemorrhagic and Thrombo-embolic Events
3.5.1 Nitric Oxide Function in Coagulation
Larry H Bernstein, MD, FCAP
Chapter 4:
Nitric Oxide and Neurodegenerative Diseases
4.1 Nitric Oxide Covalent Modifications: A Putative Therapeutic Target?
Stephen J. Williams, PhD
Chapter 5:
Bone Metabolism
5.1 Nitric Oxide in Bone Metabolism
Aviral Vatsa, PhD, MBBS
Chapter 6:
Nitric Oxide and Systemic Inflammatory Disease
6.1 Nitric Oxide and Immune Responses: Part 1
Aviral Vatsa, PhD, MBBS
6.2 Nitric Oxide and Immune Responses: Part 2
Aviral Vatsa, PhD, MBBS
6.3 Nitric Oxide Production in Systemic Sclerosis
Aviral Vatsa, PhD. MBBS
Chapter 7:
Nitric Oxide: Lung and Alveolar Gas Exchange
7.1 ’Lung on a Chip’
Ritu Saxena, Ph.D.
7.2 Low Bioavailability of Nitric Oxide due to Misbalance in Cell Free Hemoglobin in Sickle Cell Disease – A Computational Model
Anamika Sarkar, Ph.D.
7.3 The Rationale and Use of Inhaled Nitric Oxide in Pulmonary Artery Hypertension and Right Sided Heart Failure
Larry H Bernstein, MD, FCAP
7.4 Transposon-mediated Gene Therapy improves Pulmonary Hemodynamics and attenuates Right Ventricular Hypertrophy: eNOS gene therapy reduces Pulmonary vascular remodeling and Arterial wall hyperplasia
Aviva Lev-Ari, PhD, RN
Chapter 8:
Nitric Oxide and Kidney Dysfunction
8.1 Part I: The Amazing Structure and Adaptive Functioning of the Kidneys: Nitric Oxide
Larry H. Bernstein, MD, FCAP
8.2 Part II: Nitric Oxide and iNOS have Key Roles in Kidney Diseases
Larry H. Bernstein, MD, FCAP
8.3 Part III: The Molecular Biology of Renal Disorders: Nitric Oxide
Larry H. Bernstein, MD, FCAP
8.4 Part IV: New Insights on Nitric Oxide Donors
Larry H. Bernstein, MD, FCAP
8.5 The Essential Role of Nitric Oxide and Therapeutic Nitric Oxide Donor Targets in Renal Pharmacotherapy
Larry H. Bernstein, MD, FCAP
Chapter 9:
Nitric Oxide and Cancer
9.1 Crucial role of Nitric Oxide in Cancer
Ritu Saxena, Ph.D.
Leave a Reply